TER.CN - TerrAscend Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
3.0300
+0.3100 (+11.40%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close2.7200
Open2.5900
Bid3.0200 x 0
Ask3.1500 x 0
Day's Range2.4900 - 3.0600
52 Week Range2.2800 - 8.4500
Volume190,782
Avg. Volume76,902
Market Cap155.028M
Beta (5Y Monthly)-0.14
PE Ratio (TTM)N/A
EPS (TTM)-0.4500
Earnings DateAug. 21, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies

    TORONTO, Feb. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first global cannabis company licensed for sales in the U.S., Canada, and the EU, announced today that the terms of its previously announced US$10 million loan (the "Loan") from Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly-owned subsidiary of TerrAscend, have been amended.

  • CNW Group

    TerrAscend Utah, LLC Awarded Processing License in Utah

    TORONTO , Jan. 30, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first global cannabis company licensed for sales in the U.S., Canada , and the EU, announced today that its majority owned subsidiary, TerrAscend Utah, LLC ("TerrAscend Utah") was awarded approval for a Medical Cannabis Processor License by the Utah Department of Agriculture and Food on January 29 , 2020. TerrAscend Utah's processing facility will be located in St George , Utah. "We are pleased St. George will have a company like TerrAscend in our community," said Jeriah Threlfall , President, St George Economic Development.

  • CNW Group

    TerrAscend Announces Leadership Changes and Appoints Jason Ackerman Interim CEO

    Jason Ackerman, Executive Chairman of the Company, has been named interim CEO, replacing Michael Nashat, who will continue to serve as a member of the Company's Board of Directors and act as a strategic advisor to the Company. The changes are effective immediately.

  • CNW Group

    TerrAscend Announces Termination of Gravitas Nevada Ltd. Acquisition

    TORONTO , Jan. 27, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the U.S., and the EU, today announced the termination of the Securities Purchase Agreement (the "Agreement"), pursuant to which TerrAscend would have acquired all of the issued and outstanding equity interests of Gravitas Nevada Ltd. ("Gravitas"), a vertically-integrated business engaged in the cultivation, processing, packaging and dispensing of cannabis and cannabis related products in Nevada . Gravitas operates a retail cannabis dispensary in Las Vegas, Nevada under the trade name "The Apothecarium."  The transaction, for $33 .5mm in cash and 625 proportionate voting shares in the equity of TerrAscend equivalent to 625,000 common shares of the Company, was originally announced on February 11 , 2019.

  • Market Exclusive

    TerrAscend Gets Cultivation Permit in New Jersey

    TerrAscend (CSE: TER) (OTCQX: TRSSF) announced that it has received a permit to cultivate medical marijuana from the New Jersey Department of Health. The company's subsidiary TerrAscend NJ will immediately begin cultivation operations at its facility in Boonton Township, located in northern New Jersey. TerrAscend NJ is the second entity to receive its cultivation permit among […]The post TerrAscend Gets Cultivation Permit in New Jersey appeared first on Market Exclusive.

  • CNW Group

    TerrAscend Awarded Permit to Cultivate by New Jersey Department of Health

    TORONTO, Jan. 16, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada, the U.S., and the EU, today announced that TerrAscend NJ, LLC ("TerrAscend NJ") has been issued a permit to cultivate medical marijuana by the New Jersey Department of Health ("NJ DOH"). Cultivation operations will commence immediately at its facility in Boonton Township, located in northern New Jersey. In December 2018, TerrAscend was awarded the right to apply for one of six permits, out of 146 applications, for a vertically-integrated permit to cultivate, process and dispense medical cannabis in the State of New Jersey.

  • CNW Group

    TerrAscend Announces Closing on Upsized US$33.5 Million Non-Brokered Private Placement

    TORONTO, Jan. 13, 2020 /CNW/ - TerrAscend Corp. (CSE:TER;) ("TerrAscend" or the "Company") has completed its previously announced upsized non-brokered private placement (the "Private Placement") with orders totaling an aggregate amount of approximately US$33.5 million, inclusive of the first tranche of the Private Placement which closed on December 30, 2019. On January 10, 2019, the Company closed the second tranche of the Private Placement, issuing 3,450,127 units (each, a "Unit") at an issue price of CAD$2.45 per Unit resulting in proceeds to the Company of CAD$8,452,811.

  • CNW Group

    TerrAscend Provides Update and Closing Details for its Oversubscribed US$20 million Private Placement

    Correspondingly, the Company has increased the offering size to approximately US$30 million which has been fully allocated and is anticipated to close in two tranches. Today the Company closed the first tranche of the Private Placement, issuing 12,968,325 Units at an issue price of CAD$2.45 per Unit resulting in proceeds to the Company of CAD$31,772,412 . Each Unit consists of one common share in the capital of the Company (the "Common Shares") and one Common Share purchase warrant (a "Warrant").

  • CNW Group

    TerrAscend Provides Update and Closing Details for its Oversubscribed US$20 Million Private Placement

    Correspondingly, the Company has increased the offering size to approximately US$30 million which has been fully allocated and is anticipated to close in two tranches. Today the Company closed the first tranche of the Private Placement, issuing 12,968,325 Units at an issue price of CAD$2.45 per Unit resulting in proceeds to the Company of CAD$31,772,412. Each Unit consists of one common share in the capital of the Company (the "Common Shares") and one Common Share purchase warrant (a "Warrant").

  • CNW Group

    TerrAscend's Jason Ackerman to Present at the AltaCorp/ATB 8th Annual Institutional Investor Conference

    TORONTO, Dec. 24, 2019 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada, the US, and the EU, today announced that Executive Chairman Jason Ackerman will be speaking in a Fireside Chat at 2pm at the AltaCorp/ATB 8th Annual Institutional Investor Conference in Toronto on Tuesday, January 14, 2020. As the first North American Operator (NAO), with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use. TerrAscend is the first and only cannabis company with sales in the US, Canada, and Europe.

  • CNW Group

    TerrAscend Announces Proposed US$20 million Non-Brokered Private Placement

    Each Unit will consist of one common share in the capital of the Company (the "Common Shares") and one Common Share purchase warrant (a "Warrant"). Each Warrant will be exercisable to acquire one Common Share (a "Warrant Share") for a period of 24 months following the closing of the Offering (the "Closing") at an exercise price of CAD$3.25 per Warrant Share.

  • CNW Group

    TerrAscend Announces Agreement on Two Year Term Loan and Extension to Credit Facility

    TORONTO, Dec. 2, 2019 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend") the first and only global cannabis company licensed for sales in Canada, the US, and the EU, today announced that it has (i) extended the maturity date of its US$75 million credit facility due December 18, 2019 with funds managed by JW Asset Management LLC for up to three months and (ii) executed a term sheet with funds managed by JW Asset Management LLC to convert any amounts outstanding under the credit facility into a two-year term loan with an expected maturity of March, 2022. Jason Wild, Chairman of the Board of TerrAscend, is the President and Chief Investment Officer at JW Asset Management. In conjunction with the term sheet to convert the credit facility into a term loan, the credit facility maturity has been extended to March 15, 2020 or until such time as the parties have completed the required documentation to commence the conversion.

  • CNW Group

    Chairman Jason Wild Acquires Shares of TerrAscend

    Chairman Jason Wild Acquires Shares of TerrAscend